News Center


Press Releases
May 15, 2007 DowpharmaSM Licenses Pfēnex Expression Technology™ to Biovel Life Sciences Private Limited
May 01, 2007 DowpharmaSM Licenses PfēnexExpression Technology™to VGX Pharmaceuticals
April 30, 2007 DowpharmaSM and Cygnus Technologies, Inc. Announce Launch of Pseudomonas fluorescens Host Cell Protein Kit
February 27, 2007 Dow Global Technologies Inc. Announces License Agreement with Serum Institute of India Limited
February 22, 2007 DowpharmaSM Announces Multi-Product License Agreement with Merck
April 10, 2006 DowpharmaSM Signs Fourth Collaboration Agreement In First Quarter of 2006 for Pfēnex Expression Technology™
April 07, 2006 DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin
February 28, 2006 VGX Pharmaceuticals and DowpharmaSM Sign Research and Development Agreement for VGX’s Lead Cancer Compound
February 14, 2006 Viventia Biotech and DowpharmaSM Announce a Multi-Product Commercial License Agreement using Pfēnex Expression Technology™ from Dowpharma
December 19, 2005 Cambrex Named First Biopharmaceutical Manufacturing Partner for Pfēnex Expression Technology™ from DowpharmaSM
November 17, 2005 DOR BioPharma and DowpharmaSM Complete Feasibility Study for Production of BT-VACC™, DOR’s Recombinant Botulinum Vaccine
July 26, 2005 DOR BioPharma and Dowpharma Enter into a Joint Development Agreement for BT-VACC, DOR’s Oral Botulinum Toxin Vaccine
June 23, 2005 DowpharmaSM Announces Commercial License Agreement for Pfnex Expression Technology™ with Iomai Corporation
June 10, 2005 Smithsonian National Museum of American History - Dow Donates DNA Fermenter to National Museum of American History
April 12, 2005 Dowpharma Relaunches Web Site, Will Make Donation to UNICEF
March 07, 2005 DowpharmaSM Announces Agreement with Pfizer Inc using Pfnex Expression TechnologyTM and Dow Solvent Extraction Tech.
July 29, 2004 Dowpharma Sharpens Focus on New Expression Systems; Smithfield Facility Will be Closed
May 24, 2004 Dowpharma Consolidates Biopharmaceutical Process Development to San Diego
April 26, 2004 Dowpharma Announces Biologics Peptide Manufacture
April 08, 2004 Dow Expands Presence in Pharmaceutical Market, Uniting Existing Offers Under Dowpharma Portfolio
January 19, 2004 Dowpharma Introduces Next Generation Microbial Expression System for Production of Biotherapeutics


®™* Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow
SMServicemark of The Dow Chemical Company